Supplements of coenzyme Q10 (CoQ10) may protect or retard the development of fatty liver related to obesity, suggest findings from an animal study.
Mice fed a high fat and fructose diet and supplemented with CoQ10 had decreased levels of inflammatory and metabolic stress markers in their livers than mice fed just the high-fat diet, according to findings published in Biochemical Pharmacology.
CoQ10 has properties similar to vitamins, but since it is naturally synthesized in the body it is not classed as such. With chemical structure 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone, it is also known as ubiquinone because of its 'ubiquitous' distribution throughout the human body.
There is an ever-growing body of scientific data that shows substantial health benefits of CoQ10 supplementation for people suffering from angina, heart attack and hypertension. Other studies have reported CoQ10 may play a role in the prevention of, or benefit people already suffering from, neurodegenerative diseases.
The nutrient is also recommended to people on statins to off-set the CoQ-depleting effects of the medication.